| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $659.7M | +16.9% |
| Cost of Revenue | $486.5M | +9.9% |
| R&D Expense | $500K | +0.0% |
| SG&A Expense | $131.5M | +42.9% |
| Operating Income | -$27.1M | -854.9% |
| Interest Expense | $21.5M | +13.3% |
| Pre-tax Income | -$105.9M | -727.8% |
| Income Tax | -$18.2M | -641.1% |
| Net Income | -$87.5M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.5M | +29.6% |
| Accounts Receivable | $42.5M | +16.0% |
| Inventory | $23.6M | +29.2% |
| Current Assets | $243.9M | +30.0% |
| Total Assets | $653.7M | +17.1% |
| Current Liabilities | $160.5M | +35.9% |
| Long-term Debt | $200.8M | +40.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -131.7% |
| Capital Expenditures | $17.2M | +35.8% |
| Investing Cash Flow | -$11.3M | +30.9% |
| Financing Cash Flow | $29.7M | +518.0% |
| Free Cash Flow | -$26.3M | -263.2% |
| -401.7% |
| EPS (Basic) | -$1.14 | -322.2% |
| EPS (Diluted) | -$1.14 | -322.2% |
| Total Liabilities |
| $392.3M |
| +29.4% |
| Stockholders' Equity | $165.6M | -5.8% |